Offer - Urjas Oil for just ₹ 1
Ampirok 500/250 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Secondary and off-label uses of Ampirok 500/250 Tablet have also been mentioned below.
The correct dosage of Ampirok 500/250 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Ampirok 500/250 Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Ampirok 500/250 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Ampirok 500/250 Tablet has a Safe effect for pregnant women and Safe effect on lactating mothers. In addition, Ampirok 500/250 Tablet's effects on the liver, heart and kidney are discussed below in the Ampirok 500/250 Tablet related warnings section.
Ampirok 500/250 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Ampirok 500/250 Tablet in conditions like Kidney Disease, Kidney Disease, Jaundice. Some other conditions that can be affected by Ampirok 500/250 Tablet are listed in the contraindications section below.
Besides this, Ampirok 500/250 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for Ampirok 500/250 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Ampirok 500/250 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Ampirok 500/250 Tablet is used -
Moderate
Mild
Is the use of Ampirok 500/250 Tablet safe for pregnant women?
Ampirok is safe for pregnant women.
Is the use of Ampirok 500/250 Tablet safe during breastfeeding?
Ampirok does not show any harmful effects in lactating women.
What is the effect of Ampirok 500/250 Tablet on the Kidneys?
Ampirok may have mild side effects on the kidneys.
What is the effect of Ampirok 500/250 Tablet on the Liver?
There are no any side effects of Ampirok on the liver.
What is the effect of Ampirok 500/250 Tablet on the Heart?
Ampirok is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Ampirok 500/250 Tablet unless your doctor advises you to do so -
Is this Ampirok 500/250 Tablet habit forming or addictive?
No, you will not get addicted to Ampirok 500/250 Tablet.
Interaction between Food and Ampirok 500/250 Tablet
Eating certain foods may increase the time it takes Ampirok 500/250 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Ampirok 500/250 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Ampirok 500/250 Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ampicillin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 722-723
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 158-160
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 160-162